‘The Whole World Is In Overdose,’ Says CEO Of Company Behind Cannabis Inhaler That Enables Controlled Dosing
“The medical establishment has largely concluded that cannabis is perhaps the best treatment for people with PTSD,” Dr. Eytan Hyam, executive medical chairman of Syqe Medical and former director-general of Israel’s Health Ministry, recently told The Jerusalem Post.
However, there’s the ongoing issue with the dosing, which his company is trying to address with an original medical marijuana inhaler.
“One problem, however, is that people often go over the required amount, roll a joint every now and then, and consume too much, which can cause side effects. The unique Syqe inhaler comes with capsules that are loaded into the inhaler, and it’s impossible to consume more cannabis than what the doctor prescribed. The device also tracks the amount of cannabis consumed,” Hyam explained.
According to the Tel Aviv-headquartered company, the SyqeAir Inhaler is a device that allows patients to effectively and accurately manage their medical cannabis treatment, ensuring optimal therapeutic benefit. The SyqeAir Inhaler is CE (European standard) and MDL (Health Canada) approved and clinically validated by three clinical trials and real-world evidence publications, demonstrating its safety and efficacy. The company started selling the inhaler in 2019.
In February 2023, Syqe …